Orthofix Reaffirms FY26 Net Sales Outlook Of $850M-$860M; Reports Preliminary Q1 Net Sales Of ~$196.7M, And Non-GAAP Pro Forma Net Sales Of ~$196.4M
Company Reports Preliminary First Quarter 2026 Net Sales and Reaffirms 2026 OutlookOrthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced a strategic realignment of its Spine